Investing in Bauch Health Companies (BHC)

Bausch Health Companies (BHC) is trading around $26 in week 2 of October.

BHC has 2 catalyst events occuring in Feburary of 2019, approximate dates are:

  • FEB 15: IDP-118 for psoriasis
  • FEB 25: Loteprednol Gel 0.38% for ocular inflammation

ScreenHunter 810     Our approach is to setup for the upside leading up to and possibly beyond the 2 catalysts in February but with a limited max risk of around $2.55 per share.

The conditions:

Have you seen scaly or red patches on a person’s skin? Most likely that is psoriasis, a skin condition in which the life cycle of skin cells accelerated abnormally.
Additional information on psoriasis may be found at The Mayo clinic.

Ocular inflammation shows itself as red eye due to a number of reasons such as allergic reactions, bacterial infection, blepharitis, or corneal abrasion among other triggers.

Disclaimer: We are not financial advisors and are not providing any financial advice.  All content presented are for entertainment purposes only.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Up ↑

%d bloggers like this: